APG Asset Management N.V. Boosts Stock Position in Intuitive Surgical, Inc. $ISRG

APG Asset Management N.V. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the third quarter, Holdings Channel reports. The institutional investor owned 698,313 shares of the medical equipment provider’s stock after buying an additional 2,400 shares during the quarter. Intuitive Surgical accounts for about 0.6% of APG Asset Management N.V.’s holdings, making the stock its 25th biggest position. APG Asset Management N.V.’s holdings in Intuitive Surgical were worth $312,307,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the stock. Norges Bank purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth about $2,569,260,000. Rakuten Investment Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at about $388,436,000. Vanguard Group Inc. increased its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in Intuitive Surgical by 27.1% in the second quarter. Canada Pension Plan Investment Board now owns 1,089,293 shares of the medical equipment provider’s stock worth $591,933,000 after buying an additional 231,980 shares during the last quarter. Finally, Winslow Capital Management LLC lifted its stake in shares of Intuitive Surgical by 20.2% in the second quarter. Winslow Capital Management LLC now owns 1,342,473 shares of the medical equipment provider’s stock worth $729,513,000 after buying an additional 225,545 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $503.51 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The stock has a fifty day moving average of $529.83 and a 200 day moving average of $511.71. The stock has a market cap of $178.81 billion, a PE ratio of 63.82, a price-to-earnings-growth ratio of 3.88 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the company posted $2.21 EPS. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the transaction, the director owned 15,720 shares in the company, valued at $8,355,494.40. This trade represents a 15.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 56,409 shares of company stock valued at $30,895,377 in the last quarter. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Sanford C. Bernstein raised their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Robert W. Baird decreased their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a research note on Friday, January 23rd. Finally, Evercore dropped their price objective on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.